drugset / Trial / NCT02640313

Molecular Imaging of Plaque Vulnerability

NCT02640313

Phase 3 Unknown 14 enrolled Maastricht University Medical Center
NaSingle-groupOpen-labelDiagnostic

Summary

Accumulating data in the literature suggests that radiolabeled-choline (18F-choline) is a sensitive molecular tracer for PET imaging that is taken up in activated cells and, as such, is able to identify active inflammatory sites. The investigators hypothesize that 18F-choline is also highly taken up in vulnerable plaques in comparison to the stable ones.

Timeline

Start
2015-12
Primary completion
2024-03-01
Completion
2024-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject fluorocholine Diagnostic / imaging agent 4 mbq/kg Intravenous

Indications